MasterClass Expands Health Content with GLP-1 Weight Loss Course
Event summary
- MasterClass launched a new course on GLP-1 weight loss treatments taught by endocrinologist Dr. Rocio Salas-Whalen.
- The course addresses common patient concerns about side effects, weight regulation, muscle preservation, and dosage.
- 11% of U.S. adults now take GLP-1 medications, up from 3% two years ago, per a June 2026 Gallup survey.
- MasterClass offers 200+ classes with an annual membership, expanding into health and wellness content.
The big picture
MasterClass is expanding into health and wellness content as GLP-1 medications gain mainstream adoption. The platform's move aligns with broader trends in digital health education, positioning it to capture a growing audience seeking expert guidance on medical treatments. With 200+ classes and a subscription model, MasterClass is leveraging its existing infrastructure to diversify content offerings beyond traditional skill-based learning.
What we're watching
- Content Differentiation
- Whether MasterClass can sustain competitive advantage through specialized health content amid rising edtech competition.
- Market Timing
- The pace at which GLP-1 medication adoption will influence demand for related educational content.
- Regulatory Scrutiny
- How evolving healthcare regulations may impact the platform's ability to offer medical advice.
Related topics